157 related articles for article (PubMed ID: 6788847)
1. Activation of macrophages for tumor cell cytotoxicity: identification of indomethacin sensitive and insensitive pathways.
Drysdale BE; Shin HS
J Immunol; 1981 Aug; 127(2):760-5. PubMed ID: 6788847
[TBL] [Abstract][Full Text] [Related]
2. Lymphokine maintains macrophage activation for tumor cell killing by interfering with the negative regulatory effect of prostaglandin E2.
Taffet SM; Pace JL; Russell SW
J Immunol; 1981 Jul; 127(1):121-4. PubMed ID: 6263971
[TBL] [Abstract][Full Text] [Related]
3. Activation of murine macrophages. I. Different pattern of activation by poly I:C than by lymphokine or LPS.
Taramelli D; Varesio L
J Immunol; 1981 Jul; 127(1):58-63. PubMed ID: 6787132
[TBL] [Abstract][Full Text] [Related]
4. Induction of natural killer cell activity in mice by injection of indomethacin.
Voth R; Chmielarczyk W; Storch E; Kirchner H
Nat Immun Cell Growth Regul; 1986; 5(6):317-24. PubMed ID: 2432415
[TBL] [Abstract][Full Text] [Related]
5. The capacity of activated murine macrophages for augmented binding of neoplastic cells: analysis of induction by lymphokine containing MAF and kinetics of the reaction.
Marino PA; Adams DO
J Immunol; 1982 Jun; 128(6):2816-23. PubMed ID: 6804569
[TBL] [Abstract][Full Text] [Related]
6. Recombinant mouse gamma interferon induces the priming step in macrophage activation for tumor cell killing.
Pace JL; Russell SW; Torres BA; Johnson HM; Gray PW
J Immunol; 1983 May; 130(5):2011-3. PubMed ID: 6403616
[TBL] [Abstract][Full Text] [Related]
7. Quantification of the strength of cell-cell adhesion: the capture of tumor cells by activated murine macrophages proceeds through two distinct stages.
Somers SD; Whisnant CC; Adams DO
J Immunol; 1986 Feb; 136(4):1490-6. PubMed ID: 3080524
[TBL] [Abstract][Full Text] [Related]
8. Macrophage-mediated tumor cell killing: regulation of expression of cytolytic activity by prostaglandin E.
Taffet SM; Russell SW
J Immunol; 1981 Feb; 126(2):424-7. PubMed ID: 7451984
[TBL] [Abstract][Full Text] [Related]
9. Differences in antibody-dependent cellular cytotoxicity and activated killing of tumor cells by macrophage cell lines.
Ralph P; Nakoinz I
Cancer Res; 1981 Sep; 41(9 Pt 1):3546-50. PubMed ID: 6973392
[TBL] [Abstract][Full Text] [Related]
10. Activation of mouse macrophages for tumor cell killing. I. Quantitative analysis of interactions between lymphokine and lipopolysaccharide.
Pace JL; Russell SW
J Immunol; 1981 May; 126(5):1863-7. PubMed ID: 7217671
[TBL] [Abstract][Full Text] [Related]
11. Differential sensitivity of metastatic versus nonmetastatic mammary tumor cells to macrophage-mediated cytostasis.
Yamashina K; Fulton A; Heppner G
J Natl Cancer Inst; 1985 Oct; 75(4):765-70. PubMed ID: 3862907
[TBL] [Abstract][Full Text] [Related]
12. Macrophage activation for tumor cytotoxicity: characterization of priming and trigger signals during lymphokine activation.
Meltzer MS
J Immunol; 1981 Jul; 127(1):179-83. PubMed ID: 7240741
[No Abstract] [Full Text] [Related]
13. The activation of tumoricidal properties in macrophages of endotoxin responder and nonresponder mice by liposome-encapsulated immunomodulators.
Fogler WE; Talmadge JE; Fidler IJ
J Reticuloendothel Soc; 1983 Mar; 33(3):165-74. PubMed ID: 6834360
[TBL] [Abstract][Full Text] [Related]
14. Variable effects of indomethacin and four related compounds on lymphocyte blastogenesis and cell-mediated cytotoxicity.
Rojo JM; Barasoain I; Portolés A
Int J Clin Pharmacol Ther Toxicol; 1981 Sep; 19(9):420-4. PubMed ID: 6795137
[TBL] [Abstract][Full Text] [Related]
15. The effect of adherence on the in vitro induction of cytocidal activity by macrophages.
Friedman A; Beller DI
Immunology; 1987 Aug; 61(4):469-74. PubMed ID: 3127324
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of macrophage tumoricidal activity by immune complexes and altered erythrocytes.
Esparza I; Green R; Schreiber RD
J Immunol; 1983 Nov; 131(5):2117-21. PubMed ID: 6415160
[TBL] [Abstract][Full Text] [Related]
17. In vitro induction of tumoricidal and suppressor macrophages by lymphokines: possible feedback regulation.
Taramelli D; Holden HT; Varesio L
J Immunol; 1981 Jun; 126(6):2123-8. PubMed ID: 6453155
[TBL] [Abstract][Full Text] [Related]
18. Defective tumoricidal capacity of macrophages from P/J mice: characterization of the macrophage cytotoxic defect after in vivo and in vitro activation stimuli.
Boraschi D; Meltzer MS
J Immunol; 1980 Aug; 125(2):771-6. PubMed ID: 6993562
[TBL] [Abstract][Full Text] [Related]
19. Taxol provides a second signal for murine macrophage tumoricidal activity.
Manthey CL; Perera PY; Salkowski CA; Vogel SN
J Immunol; 1994 Jan; 152(2):825-31. PubMed ID: 7506736
[TBL] [Abstract][Full Text] [Related]
20. Activation of tumor-cytostatic macrophages with the antitumor agent 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1H-imidazole-2-yl)hydrazone] dihydrochloride (bisantrene).
Wang BS; Lumanglas AL; Ruszala-Mallon VM; Durr FE
Cancer Res; 1984 Jun; 44(6):2363-7. PubMed ID: 6426780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
